Role of Skeletal Muscle Nitric Oxide Production in Age-related Fatigue and Fatigability
NCT01059994 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2019-02-11
Summary
This is a pilot study funded by the National Institutes of Health. In this project, we will investigate the potential effect of skeletal muscle nitric oxide (NO) production on muscle strength and physical function in older individuals. We propose to test a new method that may enable simultaneous determination of both vascular and skeletal muscle NO production for the first time in humans. Further, we will determine whether augmentation of NO-mediated responses, by administration of sildenafil citrate (Viagra), reduces fatigue and fatigability in older individuals.
Conditions
- Fatigue
- Aging
Interventions
- DRUG
-
Placebo sildenafil
Oral, daily, 1 week.
- DRUG
-
Sildenafil
oral, 25mg, daily for 1 week
Sponsors & Collaborators
-
The University of Texas Medical Branch, Galveston
lead OTHER
Principal Investigators
-
William Durham, Ph.D. · University of Texas
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2013-07-31
- Completion
- 2013-07-31
Countries
- United States
Study Locations
More Related Trials
-
Smoking Cessation and Functional CT Assessment
NCT03382106 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of Sildenafil on the Pulmonary Circulation in Healthy Trained and Untrained Humans
NCT04985929 ·Status: COMPLETED ·Phase: PHASE2
-
Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension
NCT00872170 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food.
NCT01254396 ·Status: COMPLETED ·Phase: PHASE1
-
The Assessment of Right Ventricular Contractility in Response to Sildenafil
NCT00742014 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.
NCT02129725 ·Status: COMPLETED ·Phase: PHASE4
-
Tadalafil and Sildenafil for Duchenne Muscular Dystrophy
NCT01359670 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Sildenafil in Acute Pulmonary Embolism
NCT04283240 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Endurance Performance at Altitude
NCT03710369 ·Status: COMPLETED ·Phase: NA
-
Study of Sildenafil in Patient With Heart Failure.
NCT00309816 ·Status: COMPLETED ·Phase: PHASE3
-
Sildenafil Efficacy Study on Time Walk From Peripheral Arterial Desease Patients (Stade II) With Arterial Claudication
NCT02832570 ·Status: COMPLETED ·Phase: PHASE3
-
Exercise Oscillatory Breathing and Sildenafil in Heart Failure
NCT01185925 ·Status: COMPLETED ·Phase: PHASE2
-
Acute Hemodynamic Effects of Sildenafil in Patients With Severe Aortic Stenosis
NCT01060020 ·Status: COMPLETED ·Phase: PHASE4
-
Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous Fistula
NCT02414204 ·Status: COMPLETED ·Phase: NA
-
Sodium Nitrate to Improve Blood Flow
NCT02847975 ·Status: COMPLETED ·Phase: PHASE1
-
Reversibility by Sildenafil of Exercise-Induced Abnormal Right Ventricular Pressure Response in ASD and VSD-Operated Patients
NCT00772135 ·Status: UNKNOWN ·Phase: NA
-
PDE5-Inhibition With Sildenafil in Chronic Heart Failure
NCT00407446 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension
NCT00155714 ·Status: WITHDRAWN ·Phase: NA
-
The Safety and Efficiency of Sildenafil in the Treatment of Severe Post-capillary Pulmonary Hypertension Caused by COPD
NCT03185364 ·Status: UNKNOWN ·Phase: NA
-
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
NCT00492531 ·Status: TERMINATED ·Phase: PHASE2
-
VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension
NCT01889966 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With CFS
NCT00598585 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Regular Sildenafil on Blood Pressure and Arterial Function in Hypertension
NCT00317421 ·Status: COMPLETED ·Phase: PHASE2
-
PDE Inhibitors in DMD Study (Acute Dosing Study)
NCT01580501 ·Status: COMPLETED ·Phase: PHASE1
-
Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH
NCT01726049 ·Status: COMPLETED ·Phase: PHASE3